| Update in pituitary 2010. | |
| | |
MedLine Citation:
|
PMID: 21209039 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
This manuscript is based on an invited lecture entitled "The Year in Pituitary," presented at the 91st Annual Meeting of The Endocrine Society in San Diego, California, on June 21, 2010. The purpose of the lecture was to highlight new or evolving issues in the management of pituitary disease. Papers selected were published in major journals between January 2009 and June 2010. Issues addressed include the safety of cabergoline in pregnancy, recurrence of hyperprolactinemia after dopamine agonist withdrawal, pegvisomant and hepatic dysfunction, and high-dose hydrocortisone as a predictor of mortality in patients with acromegaly. |
| | |
Authors:
|
Janet A Schlechte |
Related Documents
:
|
21315409 - Certification and maintenance of certification: updates from the american board of path... 22026009 - Serbia: a country and a cardiology society formed in 2006. 4276109 - Disability and coal workers' pneumoconiosis. 9808209 - Clinical nutrition: opportunity in a changing health care environment. 7119829 - Neurological involvement in legionellosis. 21585139 - A technical platform for future success. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 96 ISSN: 1945-7197 ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-01-06 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 1-8 Citation Subset: AIM; IM |
Affiliation:
|
Department of Internal Medicine, University of Iowa, Iowa City, Iowa 52242, USA. janet-schlechte@uiowa.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, b...
Next Document: Update in thyroidology 2010.